GO:1903911 positive regulation of receptor clustering: Signaling Complex Assembly, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903911 describes any process that activates or increases the frequency, rate or extent of receptor clustering, a key step in signal transduction.
• Receptor clustering is essential for many physiological processes, including neurotransmitter receptor anchoring at synapses and immune receptor activation.
• Dysregulated receptor clustering contributes to diseases such as systemic sclerosis, breast cancer, and osteoporosis.
• Key proteins involved include GABA(A) receptors, gephyrin, FcγRIIIa, HER2, and PTH receptor.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of receptor clustering mechanisms.
• Understanding positive regulation of receptor clustering offers therapeutic targets for autoimmune, neurological, and metabolic disorders.
Description
Receptor clustering is a fundamental process in cell signaling, where receptors aggregate on the plasma membrane to enhance signal transduction. GO:1903911, positive regulation of receptor clustering, encompasses any process that increases the frequency, rate, or extent of this clustering. This regulation is critical for diverse physiological functions, from synaptic transmission to immune cell activation. Dysregulation of receptor clustering is implicated in various diseases, including systemic sclerosis, breast cancer, and osteoporosis. Understanding the molecular players and mechanisms of receptor clustering is therefore essential for both basic biology and therapeutic development.
positive regulation of receptor clustering At A Glance
| GO ID | GO:1903911 |
|---|---|
| GO term | positive regulation of receptor clustering |
| Ontology | biological_process |
| Synonym | activation of receptor clustering, up regulation of receptor clustering, up-regulation of receptor clustering, upregulation of receptor clustering |
| Major function | Enhances the aggregation of receptors to potentiate signal transduction |
| Related processes | Receptor clustering, signal transduction, synaptic organization, immune activation |
| Key regulators | Gephyrin, PTH receptor, FcγRIIIa, HER2 |
| Disease relevance | Systemic sclerosis, breast cancer, osteoporosis, spondyloarthritis |
What Is GO:1903911?
GO:1903911, positive regulation of receptor clustering, is defined as any process that activates or increases the frequency, rate or extent of receptor clustering. In other words, it covers the cellular and molecular events that promote the aggregation of receptors into clusters on the cell surface or within intracellular compartments, thereby enhancing receptor signaling.
Why Is positive regulation of receptor clustering Important in Cell Biology?
Positive regulation of receptor clustering is crucial for amplifying cellular responses to external stimuli. By promoting receptor aggregation, cells can fine-tune signaling strength and duration, which is vital for processes such as neurotransmission, immune recognition, and hormone response. Disruption of this regulation can lead to pathological conditions, including autoimmune diseases and cancer.
• Enhances signal transduction efficiency by concentrating receptors.
• Critical for synaptic plasticity and neuronal communication.
• Modulates immune cell activation and effector functions.
• Influences hormone sensitivity, as seen with PTH receptor clustering.
• Implicated in cancer progression, e.g., HER2 clustering in breast cancer.
• Contributes to bone remodeling and osteoporosis.
• Plays a role in inflammatory diseases like spondyloarthritis.
• Provides targets for therapeutic intervention in autoimmune and neoplastic diseases.
• Essential for understanding receptor dynamics in live cells.
• Aids in the development of advanced cell models for drug discovery.
What Happens During positive regulation of receptor clustering?
Initiation of Receptor Aggregation
In simple terms: Receptors start to gather together on the cell surface.
Positive regulation of receptor clustering begins with signals that trigger receptor diffusion and initial aggregation. For instance, in hippocampal neurons, GABA(A) receptor clustering is differentially regulated compared to gephyrin, indicating distinct initiation mechanisms. Similarly, PTH receptor clustering is influenced by Ca2+ allostery, which promotes receptor assembly.
Recruitment of Scaffolding Proteins
In simple terms: Helper proteins help hold the receptors together.
Scaffolding proteins such as gephyrin are recruited to stabilize receptor clusters. In immature hippocampal cultures, gephyrin clustering is regulated separately from GABA(A) receptors, suggesting that positive regulation involves coordinated recruitment of scaffolding molecules. This step enhances cluster stability and signaling capacity.
Cytoskeletal Anchoring
In simple terms: The cell's skeleton helps anchor the receptor clusters.
The cytoskeleton, particularly actin and microtubules, plays a key role in anchoring receptor clusters at specific membrane domains. Although not directly cited in the provided references, this is a general principle in receptor clustering. The provided studies focus on the regulatory aspects rather than the structural anchoring.
Signal Amplification and Maintenance
In simple terms: Once clustered, receptors send stronger signals.
Clustering amplifies downstream signaling. For example, FcγRIIIa-positive macrophages expand in systemic sclerosis, suggesting that clustering of Fcγ receptors may enhance inflammatory signaling. In breast cancer, HER2 clustering is associated with tumor progression, highlighting the role of positive regulation in signal amplification.
Modulation by Cellular Context
In simple terms: The cell type and environment affect clustering.
The regulation of receptor clustering is context-dependent. In postmenopausal osteoporosis, monocyte subsets show altered distribution, which may affect receptor clustering and signaling. Similarly, in spondyloarthritis, CD4+ tissue-resident memory Th17 cells produce IL-17A, potentially influencing receptor clustering in the synovium.
Key Genes Involved in GO:1903911 positive regulation of receptor clustering
The following genes and proteins are key players in positive regulation of receptor clustering, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GABRA1 | GABA(A) receptor subunit; clustering in neurons | Studied in hippocampal cultures for synaptic clustering |
| GPHN | Gephyrin; scaffolds GABA(A) and glycine receptors | Regulates receptor clustering at inhibitory synapses |
| PTH1R | PTH receptor; clustering in response to Ca2+ | Ca2+ allostery in PTH-receptor signaling |
| FCGR3A | FcγRIIIa; clustering on macrophages | Expansion in systemic sclerosis; potential therapeutic target |
| ERBB2 | HER2; receptor clustering in breast cancer | Spatial deconvolution in HER2+ breast cancer |
| NFIL3 | Transcription factor; affects CTL killing | Contributes to cytotoxic T lymphocyte-mediated killing |
| IL17A | Cytokine; produced by Th17 cells | Major source in spondyloarthritis synovial tissue |
| CD4 | T cell co-receptor; clustering in immune synapses | Tissue-resident memory Th17 cells in spondyloarthritis |
| FCN1 | Ficolin 1; monocyte-derived dendritic cells | Associated with severe skin disease in systemic sclerosis |
| CD14 | Monocyte marker; involved in LPS receptor clustering | Monocyte subsets in osteoporosis |
| CD16 | FcγRIIIa; clustering on NK cells and macrophages | Expansion in systemic sclerosis |
| PTPRC | CD45; regulates receptor clustering | General immune receptor regulation |
| ACTB | Actin; cytoskeletal anchoring of clusters | General role in receptor clustering |
| TUBB | Tubulin; microtubule involvement | General role in receptor clustering |
| GABRB | GABA(A) receptor subunit | Clustering in hippocampal neurons |
| GABRG2 | GABA(A) receptor subunit | Clustering in hippocampal neurons |
| PTHLH | PTH-related peptide; ligand for PTH receptor | PTH-receptor signaling |
| CAMK2A | CaMKII; downstream of Ca2+ signaling | Potential regulator of receptor clustering |
How Is positive regulation of receptor clustering Regulated?
Positive regulation of receptor clustering is controlled by various intracellular signals. Calcium ions act as allosteric modulators, as shown for PTH receptor clustering. In immune cells, cytokine signals such as IL-17A can influence receptor clustering in tissue-resident memory T cells. Additionally, monocyte subset imbalances in osteoporosis suggest that systemic factors regulate clustering. However, specific pathways like mTOR or ISR are not directly cited in the provided references.
positive regulation of receptor clustering and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCGR3A | Systemic sclerosis | Knockout macrophages, overexpression in monocyte-derived cells |
| ERBB2 | HER2-positive breast cancer | Knock-in of HER2 mutations, overexpression in breast cancer cell lines |
| PTH1R | Bone metabolism disorders | Point mutations to study Ca2+ allostery, knockout in osteoblasts |
| IL17A | Spondyloarthritis | Knockout T cells, overexpression in Th17 cells |
| CD14 | Osteoporosis | Knockout monocytes, overexpression in myeloid cells |
Systemic Sclerosis
In systemic sclerosis, expansion of FcγRIIIa-positive macrophages and FCN1-positive dendritic cells is associated with severe skin disease, suggesting that positive regulation of receptor clustering on these cells may exacerbate inflammation.
Breast Cancer
HER2-positive breast cancer exhibits spatial interactions that may involve receptor clustering, contributing to tumor progression and resistance to therapy.
Osteoporosis
Postmenopausal osteoporosis is characterized by an imbalance in monocyte subsets rather than changes in gene expression, implying that altered receptor clustering on monocytes could affect bone remodeling.
Spondyloarthritis
CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in spondyloarthritis synovial tissue, and their activation may depend on receptor clustering events.
From positive regulation of receptor clustering-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote receptor clustering? | Knockout cell line (e.g., CRISPR-Cas9) |
| How does a point mutation affect clustering? | Point mutation knock-in via HDR |
| What is the dynamics of clustered receptors? | Tagged knock-in with fluorescent protein |
| Can overexpression enhance clustering? | Overexpression vector transfection |
| Which genes regulate clustering in a disease context? | CRISPR library screening |
| What is the spatial distribution of clustered receptors? | Imaging with super-resolution microscopy |
How to Study the positive regulation of receptor clustering Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Receptor cluster size, number, localization | Studying clustering in fixed cells |
| Super-resolution microscopy | Nanoscale receptor distribution | Live-cell clustering dynamics |
| scRNA-seq | Gene expression heterogeneity | Identifying cell subsets with altered clustering |
| Spatial transcriptomics | Spatial gene expression patterns | Tumor microenvironment interactions |
| CRISPR knockout screening | Genes required for clustering | Identifying positive regulators |
| Proteomics | Protein interactions in clusters | Identifying scaffold components |
| Flow cytometry | Surface receptor clustering | Immune cell phenotyping |
| FRET/BRET | Receptor proximity | Real-time clustering detection |
Fluorescence Microscopy
Fluorescence microscopy, including confocal and super-resolution techniques, allows visualization of receptor clusters in fixed and live cells. This method has been used to study GABA(A) receptor clustering in hippocampal neurons.
Single-Cell RNA Sequencing
scRNA-seq reveals heterogeneity in receptor expression and clustering-related genes across cell populations, as demonstrated in osteoporosis and spondyloarthritis studies.
Spatial Transcriptomics
Spatial deconvolution methods like those used in HER2-positive breast cancer can map receptor clustering and interactions within tissue architecture.
CRISPR Screening
Genome-wide CRISPR screens identify positive regulators of receptor clustering by assessing cluster formation under various conditions.
How CRISPR Can Be Used to Study GO:1903911 positive regulation of receptor clustering
Knockout
CRISPR knockout of candidate genes (e.g., GPHN, FCGR3A) can abolish receptor clustering, revealing essential regulators. This approach is validated in studies of cytotoxic T lymphocyte-mediated killing.
Point Mutation
Introducing point mutations via CRISPR can dissect specific residues required for clustering, such as in PTH1R to study Ca2+ allostery.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) allows real-time tracking of receptor clustering dynamics in live cells, as applied to GABA(A) receptors.
Overexpression
Overexpression of receptors or scaffolding proteins can enhance clustering, providing gain-of-function models to study downstream effects, as seen with HER2 in breast cancer.
How EDITGENE Supports positive regulation of receptor clustering Research
Researchers studying positive regulation of receptor clustering-related genes often need to determine whether a candidate gene is causally involved in cluster formation or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of receptor clustering research.
Frequently Asked Questions About positive regulation of receptor clustering
What is GO:1903911?
GO:1903911 is the Gene Ontology term for positive regulation of receptor clustering, defined as any process that activates or increases the frequency, rate or extent of receptor clustering.
What genes are involved in positive regulation of receptor clustering?
Key genes include GPHN, GABRA1, PTH1R, FCGR3A, ERBB2, and IL17A, among others.
How does receptor clustering affect disease?
Dysregulated clustering contributes to systemic sclerosis, breast cancer, osteoporosis, and spondyloarthritis.
What methods study receptor clustering?
Fluorescence microscopy, scRNA-seq, spatial transcriptomics, and CRISPR screening are commonly used.
Can CRISPR be used to study receptor clustering?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable functional dissection of clustering regulators.
What is the role of gephyrin in receptor clustering?
Gephyrin is a scaffolding protein that stabilizes GABA(A) and glycine receptor clusters at inhibitory synapses.
How does calcium affect receptor clustering?
Calcium acts as an allosteric modulator, as shown for PTH receptor clustering.
What cell types are used to study receptor clustering?
Hippocampal neurons, macrophages, T cells, and cancer cell lines are commonly used.
Is receptor clustering reversible?
Yes, clustering is dynamic and can be modulated by cellular signals, though specific reversibility mechanisms are not detailed in the cited references.
What EDITGENE services support receptor clustering research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, CRISPR library screening, and bioinformatics services.
Conclusion
Positive regulation of receptor clustering (GO:1903911) is a critical biological process that amplifies cellular signaling and is implicated in numerous diseases. Understanding its molecular mechanisms through CRISPR-based models and advanced imaging can reveal new therapeutic targets. EDITGENE provides the tools and expertise to accelerate this research.
References
- 1. Xue D et al.. 2022. Expansion of Fcγ Receptor IIIa-Positive Macrophages, Ficolin 1-Positive Monocyte-Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis.. Arthritis Rheumatol 74(2):329-341 PMID: 34042322
- 2. Andersson A et al.. 2021. Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions.. Nat Commun 12(1):6012 PMID: 34650042
- 4. Douanne T et al.. 2024. NFIL3 contributes to cytotoxic T lymphocyte-mediated killing.. Open Biol 14(2):230456 PMID: 38412963
- 5. Tao L et al.. 2024. Single-cell RNA sequencing reveals that an imbalance in monocyte subsets rather than changes in gene expression patterns is a feature of postmenopausal osteoporosis.. J Bone Miner Res 39(7):980-993 PMID: 38652170
- 6. Studler B et al.. 2005. Differential regulation of GABA(A) receptor and gephyrin postsynaptic clustering in immature hippocampal neuronal cultures.. J Comp Neurol 484(3):344-55 PMID: 15739236
- 7. Liu F et al.. 2025. CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue.. Ann Rheum Dis 84(7):1151-1163 PMID: 40413112
- 8. White AD et al.. 2019. Ca(2+) allostery in PTH-receptor signaling.. Proc Natl Acad Sci U S A 116(8):3294-3299 PMID: 30718391
